Question 1: Investment constraints
Innovate UK wants to give equal opportunity to companies seeking funding and investment across the whole of the UK. Do you have any constraints in terms of investments?
- about any geographic constraints in terms of where you can invest, or any UK regions where you are more likely to invest
- whether geographic overlap with your existing portfolio influences your decision to invest
- about anything that restricts when you can invest or for how long
- if you need to syndicate before investing
- if you are looking for a new deal flow or for a grant and further investment for companies in your existing portfolio, both of which are eligible for the Precision Medicine Investment Accelerator
Question 2: Capital
What approach will you take to investing capital into the Precision Medicine Investment Accelerator?
- how much capital you potentially have available to invest into the Precision Medicine Investment Accelerator competition
- how much further capital may be available to follow your investment
- the total length of time you can hold an investment
- how much capital you can typically put into your investments each round and over the lifetime of each company
- the typical investment size or any boundary levels of capital at each stage of investment, be it pre-seed, seed, series A or something else
Question 3: Investment timing and rounds
Innovate UK typically issues grants to young companies developing highly innovative products which can be a high risk for investment.
- the stage of company development when you typically invest, be it pre-seed, seed, series A or something else
- if you invest in innovations and companies as early as proof-of-concept stage
- if you invest in university spin-out companies, and any constraints on the universities you work with
- the number of companies in your current portfolio that took first investment from you in the range of £200,000 to £750,000
- if you typically fund over several rounds of investment
Question 4: Investment scope
The Precision Medicine Investment Accelerator will increase funding and investment in opportunities that improve the way we diagnose, monitor and treat disease to provide the right treatment, at the right time, to the right patient.
We will use your answer to publicise your offer to companies applying for funding and investment. If you are successful it will be available to applicants through the Innovate UK website. We may also use it at briefing events and in other Innovate UK documents linked to the Precision Medicine Investment Accelerator.
Describe or explain:
- your interest in the field of precision medicine and why you believe it is an exciting area for investment
- the stage of company development where you may potentially invest through the Precision Medicine Investment Accelerator, such as proof-of-concept, pre-seed, seed or series A
- how many investments you typically make a year, both into new companies and companies already within your portfolio
- the investment opportunities in precision medicine you are interested in: therapeutics, diagnostics, med-tech, AI, machine learning and informatics, or others
- any investments you currently have that could be classed as precision medicine
Question 5: Added value of your investment
Innovate UK has established the Investor Partnership Programme because we recognise the added value an investor can bring to companies beyond the investment capital itself.
Please note: we will use your answer for publicity in the same way as question 4.
Describe or explain:
- what expertise you can bring to actively build value in a business, including the development of business skills, recruitment, supply chain development, market access and so on
- what expertise you can bring to a company specifically operating in the field of precision medicine
- how your investment can use Innovate UK grant funding to help scale and grow innovative UK companies operating in the broad field of precision medicine
- what relevant sector and technology specific expertise you have
Question 6: Impact on the investor partnership programme
The Investor Partnerships Programme at Innovate UK has been established to bring private investment into early-stage and innovative UK companies earlier, wider and for longer.
Describe the impact co-investing with Innovate UK would have on this programme and your involvement in it.
Describe or explain:
- the likely impact on your fund of being an investor partner on the Precision Medicine Investment Accelerator and any wider impact on your business
- the difference being an investor partner would make to your fund, such as giving you a faster route to market, reducing risk and so on
- how being an investor partner would change the nature of your investment activity
- what would, or would not, happen if your application to become an investor partner is unsuccessful